Lamivudine for the treatment of membranous glomerulopathy: CONCLUSION

Lamivudine appears to be a potentially safe and effective means of treating adults with glomerular diseaseassociated with HBV. Lamivudine should be considered a potential alternative to interferon for HBV patients with glomerulopathy who are intolerant of or unwilling to take interferon-based therapy. Whether a patient with HBV-related MGN will be more responsive to lamivudine, as [...]